Simplex Trading
ORMP icon

Simplex Trading’s Oramed Pharmaceuticals ORMP Stock Holding History

Simplex Trading’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$340 Buy
+100
New +$339 ﹤0.01% 8781
2025
Q2 		– Sell
-800
Closed -$1K – 9453
2025
Q1 		$1K Sell
800
-700
-47% -$1.61K ﹤0.01% 8273
2024
Q4 		$3K Buy
+1,500
New +$3.56K ﹤0.01% 7904
2024
Q3 		– Sell
-4,100
Closed -$10K – 9273
2024
Q2 		$10K Buy
4,100
+2,700
+193% +$6.42K ﹤0.01% 7436
2024
Q1 		$4K Buy
+1,400
New +$3.92K ﹤0.01% 8146
2023
Q4 		– Sell
-2,800
Closed -$7K – 9543
2023
Q3 		$7K Sell
2,800
-300
-10% -$945 ﹤0.01% 7443
2023
Q2 		$11K Sell
3,100
-2,000
-39% -$6.41K ﹤0.01% 7330
2023
Q1 		$11K Sell
5,100
-2,700
-35% -$8.58K ﹤0.01% 7471
2022
Q4 		$93K Buy
7,800
+3,100
+66% +$24.1K ﹤0.01% 5174
2022
Q3 		$30K Buy
4,700
+4,200
+840% +$34K ﹤0.01% 7081
2022
Q2 		$2K Sell
500
-5,700
-92% -$30.5K ﹤0.01% 9399
2022
Q1 		$53K Sell
6,200
-3,300
-35% -$33.8K ﹤0.01% 7049
2021
Q4 		$135K Sell
9,500
-300
-3% -$6.27K ﹤0.01% 5769
2021
Q3 		$130K Hold
9,800
– – ﹤0.01% 6246
2021
Q2 		$131K Buy
+9,800
New +$112K ﹤0.01% 6348
2021
Q1 		– Sell
-4
Closed -$1K – 9703
2020
Q4 		$1K Buy
+4
New +$13 ﹤0.01% 8141
2020
Q1 		– Sell
-324
Closed -$166K – 8074
2019
Q4 		$166K Buy
324
+307
+1,806% +$1.15K ﹤0.01% 3956
2019
Q3 		$5K Buy
17
+13
+325% +$43 ﹤0.01% 6624
2019
Q2 		$1K Buy
+4
New +$14 ﹤0.01% 6896
2019
Q1 		– Sell
-10
Closed -$3K – 7653
2018
Q4 		$3K Hold
10
– – ﹤0.01% 6444
2018
Q3 		$4K Buy
+10
New +$52 ﹤0.01% 6855
2016
Q2 		– Sell
-9
Closed -$1K – 6285
2016
Q1 		$1K Buy
+9
New +$60 ﹤0.01% 5193
2015
Q1 		– Sell
-2
Closed -$1K – 5420
2014
Q4 		$1K Buy
+2
New +$13 ﹤0.01% 4213

Other funds holding ORMP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $102M AUM
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $25B AUM 18.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Simplex Trading's ORMP Position: Q1 2026 in Review

Simplex Trading reduced its Oramed Pharmaceuticals (ORMP) stake by 67% in Q1 2026, selling an estimated $2.62K and leaving 374 shares worth $1.27K. The position accounts for ﹤0.01% of the portfolio, ranked #8517.

Simplex Trading first reported a position in ORMP in Q4 2014 and has held it in 21 quarters since. The position peaked at $462K in Q4 2022. 64 funds tracked by Wall St. Rank hold ORMP as of Q1 2026.

  • Simplex Trading held 374 shares of Oramed Pharmaceuticals worth $1.27K as of Q1 2026.
  • Simplex Trading sold 771 Oramed Pharmaceuticals shares in Q1 2026, an estimated $2.62K.
  • Oramed Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #8517 holding.
  • Simplex Trading first reported a position in Oramed Pharmaceuticals in Q4 2014 and has held it in 21 quarters since.
  • Simplex Trading's Oramed Pharmaceuticals position peaked at $462K in Q4 2022.
  • 64 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.